Named on 2 rounds in the feed, most often in Biotech.
Rounds from 2023-11-15 to 2026-09-29
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
52North A University of Cambridge medtech spinout | Funding round Verified against 4 of 5 sources | $4.2M | 2026-09-29 | [ PART ] |
T-Therapeutics A biotechnology company developing next-generation T cell receptor (TCR) T cell engager (TCE) therapeutics for cancer and autoimmune diseases | Series A Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $59.8M | 2023-11-15 | [ PART ] |